MannKind wins FDA approval for 80 mg Furoscix
MannKind (NASDAQ:MNKD) received FDA approval for Furoscix ReadyFlow, an 80 mg/mL autoinjector treating edema in adults with heart or kidney disease.

Crypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.
MannKind (NASDAQ:MNKD) received FDA approval for Furoscix ReadyFlow, an 80 mg/mL autoinjector treating edema in adults with heart or kidney disease.
Janus Electric (ASX:JNS) secured firm commitments to raise approximately $7.7 million before costs through a private placement.
Pendle (CRYPTO:PENDLE) has launched an artificial intelligence-powered trading agent that is designed to assist users with market analysis and trading strategies across decentralised finance.
Axtec (ASX:AXI) signed a three-year partnership agreement with MRI Software Australia starting Aug. 1.
Binance (private) has expanded its partnership with anti-trafficking charity Stop The Traffik to strengthen efforts to identify and disrupt human trafficking networks that use cryptocurrency.
Almonty Industries (ASX:AII) has secured approval to voluntarily delist from the ASX on Sept. 1.
ASX (ASX:ASX) announced that CFO Andrew Tobin has advised the board of his intention to retire following a four-year tenure leading the finance function.
Gold miner Regis Resources (ASX:RRL) achieved its annual production target, producing 379 thousand ounces of gold in financial year 2026.
NVR (NYSE:NVR) reported its second-quarter 2026 financial results, generating $2.33 billion in consolidated revenues, a decline from the $2.60 billion reported in the same period last year.
Bread Financial (NYSE:BFH) reported its second-quarter 2026 financial results, generating $993 million in revenue.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy